Snowball logo
logo
4570_logo

Immuno-Biological Laboratories Co Ltd

4570 TSE
¥1,043.00+¥44.00  (4.4%)
Estimate
P/E
29.5
EPS
35.34
Beta
-0.031
Growth
Revenue, YoY
-9.19%
Net income, YoY
-30.15%
Dividends
Dividend yield
0.58%
Annual payout
¥6.00
Next ex. div date
March 30, 27
Div.rating
About the company
Ticker
4570
ISIN
JP3921300004
Country
Japan
Sector (GICS)
Healthcare
Immuno-Biological Laboratories Co., Ltd. engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide. The company offers ELILSA, an assay kit to quantitatively measure targeted substances; and support research services on Alzheimer's disease, metabolic syndrome, and cancer, as well as customized services for production of customized antibodies and development of ELISA systems. It also provides LipoSEARCH, a customized services for profiling and analyzing of lipoprotein through gel-filtration high performance liquid chromatography method that can profile various clinical samples, such as tiny plasma or serum samples from both small animals and human beings for broad range of research fields including lipid metabolism, development of drugs for life-style related diseases, development of functional supplemental foods, and clinical studies. In addition, the company offers LipoTEST, a support tool for diagnostic and health checks at animal clinics; and customized biomarker testing services for Life-style related diseases. Further, it operates protein production business using transgenic silkworms for manufacturing of antibodies for research reagents and diagnostic products; human collagen for cosmetic materials; development of proteins for use in drugs; and other proteins production. The company was incorporated in 1982 and is headquartered in Fujioka, Japan.

Frequently asked questions

What sector does Immuno-Biological Laboratories Co Ltd (4570) operate in?

Immuno-Biological Laboratories Co Ltd belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Immuno-Biological Laboratories Co Ltd (4570) current stock price?

As of the latest data, Immuno-Biological Laboratories Co Ltd stock price is ¥1,043, with a previous close of ¥999. Immuno-Biological Laboratories Co Ltd gained ¥44 in the last trading session, representing a 4.4% increase.

What is Immuno-Biological Laboratories Co Ltd (4570) current market capitalization?

Immuno-Biological Laboratories Co Ltd market cap is approximately 9.71 billion.

What is Immuno-Biological Laboratories Co Ltd (4570) Earnings Per Share (EPS)?

The trailing EPS is ¥35.

What is Immuno-Biological Laboratories Co Ltd (4570) Price-to-Earnings (P/E) ratio?

Immuno-Biological Laboratories Co Ltd current P/E ratio is 29.51.

What is Immuno-Biological Laboratories Co Ltd (4570) EBITDA?

Immuno-Biological Laboratories Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 62.92 million.

Does Immuno-Biological Laboratories Co Ltd (4570) pay dividends?

Yes. Immuno-Biological Laboratories Co Ltd pays annual dividends with an annualized yield of 0.58% and an estimated annual payout of ¥6 per share.

When is the next ex-dividend date for Immuno-Biological Laboratories Co Ltd (4570)?

The next ex-dividend date is scheduled for March 30, 2027.

What is Immuno-Biological Laboratories Co Ltd (4570) beta (volatility) score?

Immuno-Biological Laboratories Co Ltd has a beta of -0.031, indicating lower volatility than the overall market.